China Resources Pharmaceutical Group Ltd. (640) Q4 2025 Earnings Report
DE:640 Q4 2025 EPS Results
- Actual EPS
- EUR 0.04
- Consensus EPS
- EUR 0.03
- Beat/Miss
- Beat by +EUR 0.01
- One Year Ago EPS
- EUR 0.02
DE:640 Q4 2025 Revenue Results
- Actual Revenue
- EUR 17.18B
- Expected Revenue
- EUR 18.00B
- Beat/Miss
- Missed by -EUR 817.62M
- YoY Revenue Growth
- +7.67%
Earnings Announcement Details
- Quarter
- Q4 2025
- Date
- 03/25/2026
- Time
- After Close
- Conference Call
- Wednesday, March 25, 2026
Q4 2025 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q4 2025 Earnings Slide Deck
Q4 2025 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:640 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Aug 24, 2026 | 2026 (Q2) | 0.050.05 | 0.04 | 6.06% (+0.00) | |
| Mar 25, 2026 | 2025 (Q4) | 0.030.04 | 0.02 | 176.79% (+0.03) | |
| Aug 26, 2025 | 2025 (Q2) | 0.050.04 | 0.06 | -19.51% (-0.01) | |
| Mar 26, 2025 | 2024 (Q4) | 0.030.02 | 0.02 | -32.53% (-0.01) | |
| Oct 29, 2024 | 2024 (Q3) | ―- | 0.06 | ― | |
| Aug 29, 2024 | 2024 (Q2) | 0.060.06 | 0.06 | -8.07% (-0.00) | |
| Mar 26, 2024 | 2023 (Q4) | 0.030.02 | 0.02 | -7.26% (-0.00) | |
| Oct 30, 2023 | 2023 (Q3) | ―- | 0.06 | ― | |
| Aug 31, 2023 | 2023 (Q2) | ―0.06 | 0.06 | 6.44% (+0.00) | |
| Mar 30, 2023 | 2022 (Q4) | 0.020.02 | 0.02 | 4.68% (+0.00) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
